These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28342863)

  • 41. Assessment of apelin, apelin receptor, resistin, and adiponectin levels in the primary tumor and serum of patients with esophageal squamous cell carcinoma.
    Diakowska D; Markocka-Mączka K; Nienartowicz M; Rosińczuk J; Krzystek-Korpacka M
    Adv Clin Exp Med; 2019 May; 28(5):671-678. PubMed ID: 30640413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative blood-routine markers and prognosis of esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study.
    Hu D; Lin X; Chen Y; Chang Q; Chen G; Li C; Zhang H; Cui Z; Liang B; Jiang W; Ji K; Huang J; Peng F; Zheng X; Niu W
    Oncotarget; 2017 Apr; 8(14):23841-23850. PubMed ID: 27852044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
    Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
    World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications.
    Li SP; Guan QL; Zhao D; Pei GJ; Su HX; Du LN; He JX; Liu ZC
    Med Sci Monit; 2016 May; 22():1654-62. PubMed ID: 27184872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma.
    Choi MK; Kim GH; I H; Park SJ; Lee MW; Lee BE; Park DY; Cho YK
    J Gastroenterol Hepatol; 2019 Mar; 34(3):552-560. PubMed ID: 30426559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
    Jiao XL; Chen D; Wang JG; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Negative expression of PTEN identifies high risk for lymphatic-related metastasis in human esophageal squamous cell carcinoma.
    Sun Z; Ji N; Bi M; Zhang Z; Liu X; Wang Z
    Oncol Rep; 2015 Jun; 33(6):3024-32. PubMed ID: 25963289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of FAM3C in esophageal squamous cell carcinoma.
    Zhu YH; Zhang B; Li M; Huang P; Sun J; Fu J; Guan XY
    Diagn Pathol; 2015 Oct; 10():192. PubMed ID: 26498278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis.
    Arigami T; Okumura H; Matsumoto M; Uchikado Y; Uenosono Y; Kita Y; Owaki T; Mori S; Kurahara H; Kijima Y; Ishigami S; Natsugoe S
    Medicine (Baltimore); 2015 Oct; 94(42):e1702. PubMed ID: 26496280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
    Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
    Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma.
    Cheng J; Liu Q; Jin H; Zeng D; Liao Y; Zhao Y; Gao X; Zheng G
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165966. PubMed ID: 32931889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
    Xie JJ; Guo JC; Wu ZY; Xu XE; Wu JY; Chen B; Ran LQ; Liao LD; Li EM; Xu LY
    Hum Pathol; 2016 Feb; 48():69-75. PubMed ID: 26772401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
    Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
    Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
    BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Serum miRNAs as new biomarkers for esophageal squamous cell carcinoma].
    Li YY; Liu ZG; Wang L; Yuan YY; Liu P; Wang LS
    Yi Chuan; 2015 Apr; 37(4):315-320. PubMed ID: 25881696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma.
    Wang XP; Li XH; Zhang L; Lin JH; Huang H; Kang T; Mao MJ; Chen H; Zheng X
    BMC Cancer; 2016 Jul; 16():516. PubMed ID: 27444612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced EBP50 expression or mis-localization of the EBP50 protein is associated with the malignant progression of esophageal squamous cell carcinoma.
    Wang L; Du YR; Ji MY; Wang W; Zhan N; Zhou QS; Dong WG
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3854-63. PubMed ID: 25555876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.